Fujian Amount Biotechnology Co., Ltd.(referred to as " Amount Biotechnology") was established in 2022, focusing on innovative technology research and application in the field of biomedicine, and committed to providing efficient and accurate sample processing and diagnostic solutions for global customers. The company has exclusive global technological advantages in the fields of biomacromolecule concentration and separation, extracellular vesicle preparation, and activity analysis. Its core patents cover China, the European Union, Japan, and the United Kingdom, and are gradually expanding to the global market.